Completed PHASE4 INTERVENTIONAL NCT00129909

STITCH (Simplified Therapeutic Intervention To Control Hypertension)

Evaluation of a Primary Treatment Algorithm Using Fixed Dose Combination Therapy for the Management of Hypertension - Control and Intervention Arms

Sponsor: Pfizer

Conditions Hypertension

Interventions fixed dose combination therapy

Updated 6 times since 2017 Last updated: Jun 13, 2012 Started: May 31, 2005 Primary completion: Sep 30, 2006 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypertension and is currently completed. Pfizer leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer
University of Western Ontario, Canada

Data source: University of Western Ontario, Canada

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada